永恒策略(00764.HK)持有的14.84亿股中国智能健康(00348.HK)股份列账为于联营公司的投资
格隆汇10月28日丨永恒策略(00764.HK)公布,于本公布日期,该集团持有14.84亿股中国智能健康(00348.HK)股份,占中国智能健康已发行股本18.86%。
于2019年10月28日,刁云峰先生辞任中国智能健康非执行董事,而执行董事张国伟先生获委任为中国智能健康执行董事,即时生效。
随着张国伟先生获委任为中国智能健康执行董事后,该集团已有两名执行董事委任于中国智能健康董事会,而该集团被视为对中国智能健康具有重大影响力。据此,该集团持有的14.84亿股中国智能健康股份乃根据香港会计准则第28号于联营公司及合营企业的投资列账为于联营公司的投资,而非根据香港财务报告准则第9号金融工具于本集团综合财务报表中列账为按公平值计入损益表的金融资产,自2019年10月28日起生效。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.